A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating
inflammation, or treating cancer may comprise administering a
therapeutically effective amount of an extract of Combretum laurifolium
Mart. to a patient. A medicament as described herein may comprise a
pharmaceutically acceptable vehicle and a therapeutically effective
amount of an extract of Combretum laurifolium Mart. suspended in the
vehicle. A method of making an extract of Combretum laurifolium Mart. may
comprise creating a component solution by treating Combretum laurifolium
Mart. material with an extractor and a solvent and producing an extract
by at least partially removing liquid from the component solution. An
extract of Combretum laurifolium Mart. may comprise components extracted
using various solvents.